Stock info Bone Therapeutics | Filter  Basic-Info

Stock: Bone Therapeutics (Bel small), ISIN: BE0974280126

Last Price 0.02 Max Price 0.07
Min Price 0.02 1 Year return -97.01
Avg. Target 0.00 Expected Return -100.00 %
Sector Health Care Subsector Biotechnology
Sell 0 Rating
Hold 0 Concensus
Buy 0
Annual report 2017

Loading...

Contact info:Street: 37 Rue Auguste Piccard Postbox: 6041City: GosseliesCountry: BelgiumPhone: +32 (0)71 12.10.00Website: www.bonetherapeutics.com

Sector Review Bone Therapeutics

Loading...
Year Turnover Total sector Market share
2019 0 141,925 0.00 %
2020 1 170,231 0.00 %
2021 1 252,886 0.00 %
2022 0 238,500 0.00 %
2023 0 0 0.00 %

Advice Bone Therapeutics

Date Label Bank Label Stock Label Advice Label Price Label Diff Label
December 20, 2021 Kepler Capital Markets Bone Therapeutics Hold 0.70 84.29 %
August 31, 2021 Kepler Capital Markets Bone Therapeutics Hold 1.80 86.11 %
January 22, 2021 KBC Securities Bone Therapeutics Buy 5.20 94.42 %
October 05, 2020 Kepler Capital Markets Bone Therapeutics Buy 5.70 74.74 %
March 11, 2020 KBC Securities Bone Therapeutics Hold 4.00 30.00 %
March 11, 2020 KBC Securities Bone Therapeutics Hold 4.00 30.00 %
June 18, 2019 Kepler Capital Markets Bone Therapeutics Hold 5.70 53.86 %
April 29, 2019 Bryan Garnier Bone Therapeutics Buy 6.80 95.74 %
January 22, 2019 Kepler Capital Markets Bone Therapeutics Hold 5.00 26.00 %
November 10, 2018 KBC Securities Bone Therapeutics Buy 10.50 65.90 %
October 19, 2018 KBC Securities Bone Therapeutics Buy 14.00 75.57 %
October 19, 2018 Bryan Garnier Bone Therapeutics Buy 17.00 79.88 %
September 17, 2018 Kepler Capital Markets Bone Therapeutics Hold 10.50 64.38 %
September 15, 2018 Bryan Garnier Bone Therapeutics Buy 15.50 75.87 %
February 21, 2018 KBC Securities Bone Therapeutics Buy 11.00 68.18 %
December 18, 2017 Kepler Capital Markets Bone Therapeutics Hold 9.00 40.89 %
December 18, 2017 KBC Securities Bone Therapeutics Buy 11.00 51.64 %
December 11, 2017 Bryan Garnier Bone Therapeutics Buy 17.00 63.71 %
September 20, 2017 Kepler Capital Markets Bone Therapeutics Buy 15.00 37.27 %
September 20, 2017 KBC Securities Bone Therapeutics Buy 12.00 21.58 %
September 20, 2017 Bryan Garnier Bone Therapeutics Buy 28.00 66.39 %
August 30, 2017 KBC Securities Bone Therapeutics Buy 10.50 -1376.19 %
January 17, 2017 Bryan Garnier Bone Therapeutics Buy 28.00 63.00 %
January 17, 2017 Kepler Capital Markets Bone Therapeutics Hold 9.00 -15.11 %
January 05, 2017 Bryan Garnier Bone Therapeutics Buy 32.00 74.22 %



News Bone Therapeutics

No Records Found

Annual reports Bone Therapeutics

2017 2018 2019 2020 2021

Profile Bone Therapeutics

Bone Therapeutics

(BE0974280126)

The period from 2006 till the end of 2016 the international sector gained around 59 percent. Measured since 2011 the sector is 70 percent higher and over the past 12 months (December 2015-2016) there is a minus of 59 percent.

The past year gave good returns for Bone Therapeutics investors

Over the past year the company' stock lost around 58 percent. Over the period from December 2011 till December 2016 the stock lost on average 0 percent. Bone Therapeutics's revenues between 2011 and 2015 were very volatile and moved between 3,05 million euros and 3,82 million euros.

Over the past 5 years the Belgian company paid out dividends.

At the end of 2015 Bone Therapeutics employed at around 67 people.

Bone Therapeutics' balance mostly financed with equity

At the end of 2015 the biotech company's balance sheet equaled 50,38 million euros. Last year the total debt of the company was 22,24 million euros. This equals around 44,14 percent of the total balance sheet.

At the end of 2015 the market capitalization (the number of shares outstanding multiplied by the stock price) of the biotech company equaled around 144,6 million euros. At the end of 2015 the Belgian company had around 7,42 million stocks listed on the exchanges.

All Bone Therapeutics's annual reports can be found here. More information about Bone Therapeutics can be found it's website. .


Results Bone Therapeutics

Results
2015
2016
2017
2018
2019
2020
Revenue
0
0
0
1
0
1
Costs
14
13
13
15
10
13
Profit
-14
-13
-13
-14
-10
-12
Margin of profit
0.0
0.0
-31875.00
-1422.00
0.0
-1194.00
ROI
-50.23
-85.07
-535.71
-316.70
-510.24
-358.56

Balance Bone Therapeutics

Balance
2015
2016
2017
2018
2019
2020
Equity
28
15
2
4
2
3
Debt
22
23
23
21
20
22
Total assets
50
39
25
26
22
25
Solvency
55.88
39.57
9.46
17.44
9.16
13.41
Cash
34
20
8
8
9
15
Cashflow
-12
-11
-11
-13
-10
-16
Employees
101
94
94
0
0
Revenue per employee
0.0
0.0
0.0
0.0
0.0
Cashflow / Debt
-0.53
-0.49
-0.48
-0.61
-0.51
-0.75

Details Bone Therapeutics

Details
2016
2017
2018
2019
2020
Price
19.49
7.79
7.77
4.50
3.65
Eps
-1.90
-1.86
-1.87
-1.10
-1.02
Price/earnings-ratio
-10.26
-4.19
-4.16
-4.09
-0.02
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
2.23
0.35
0.54
0.19
0.20
Market to book
0.11
0.04
0.07
0.04
10.10
Cashflow per stock
-1.66
-1.61
-1.55
-0.97
-0.98
Stocks
7
7
8
11
16
Market Cap
133.50
53.36
64.57
48.02
0.33

Dividend Bone Therapeutics


Price info Bone Therapeutics

Date
Price
22 Mar 2024
0.02
18 Mar 2024
0.02
15 Mar 2024
0.02
12 Mar 2024
0.03
11 Mar 2024
0.03
09 Mar 2024
0.03
07 Mar 2024
0.03
01 Mar 2024
0.03
29 Feb 2024
0.03
27 Feb 2024
0.03
22 Feb 2024
0.03
21 Feb 2024
0.03
20 Feb 2024
0.03
15 Feb 2024
0.04
14 Feb 2024
0.04
13 Feb 2024
0.03
09 Feb 2024
0.04
08 Feb 2024
0.04
07 Feb 2024
0.04
06 Feb 2024
0.04
05 Feb 2024
0.04
01 Feb 2024
0.05
31 Jan 2024
0.05
30 Jan 2024
0.04
27 Jan 2024
0.04
25 Jan 2024
0.04
24 Jan 2024
0.04
23 Jan 2024
0.04
16 Jan 2024
0.06
11 Jan 2024
0.06